Regulation of CYP2J2 and EET Levels in Cardiac Disease and Diabetes
1
Department of Medicinal Chemistry, University of Washington, Seattle, WA 98101, USA
2
Cardiovascular Health Research Unit, University of Washington, Seattle, WA 98195, USA
3
Department of Medicine, University of Washington, Seattle, WA 98195, USA
4
Division of Cardiology, University of Washington, Seattle, WA 98195, USA
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2018, 19(7), 1916; https://doi.org/10.3390/ijms19071916
Received: 29 April 2018
/
Revised: 24 June 2018
/
Accepted: 25 June 2018
/
Published: 29 June 2018
(This article belongs to the Special Issue Cytochromes P450: Drug Metabolism and Bioactivation)
Cytochrome P450 2J2 (CYP2J2) is a known arachidonic acid (AA) epoxygenase that mediates the formation of four bioactive regioisomers of cis-epoxyeicosatrienoic acids (EETs). Although its expression in the liver is low, CYP2J2 is mainly observed in extrahepatic tissues, including the small intestine, pancreas, lung, and heart. Changes in CYP2J2 levels or activity by xenobiotics, disease states, or polymorphisms are proposed to lead to various organ dysfunctions. Several studies have investigated the regulation of CYP2J2 and EET formation in various cell lines and have demonstrated that such regulation is tissue-dependent. In addition, studies linking CYP2J2 polymorphisms to the risk of developing cardiovascular disease (CVD) yielded contradictory results. This review will focus on the mechanisms of regulation of CYP2J2 by inducers, inhibitors, and oxidative stress modeling certain disease states in various cell lines and tissues. The implication of CYP2J2 expression, polymorphisms, activity and, as a result, EET levels in the pathophysiology of diabetes and CVD will also be discussed.
View Full-Text
▼
Show Figures
Scheme 1
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited
MDPI and ACS Style
Aliwarga, T.; Evangelista, E.A.; Sotoodehnia, N.; Lemaitre, R.N.; Totah, R.A. Regulation of CYP2J2 and EET Levels in Cardiac Disease and Diabetes. Int. J. Mol. Sci. 2018, 19, 1916. https://doi.org/10.3390/ijms19071916
AMA Style
Aliwarga T, Evangelista EA, Sotoodehnia N, Lemaitre RN, Totah RA. Regulation of CYP2J2 and EET Levels in Cardiac Disease and Diabetes. International Journal of Molecular Sciences. 2018; 19(7):1916. https://doi.org/10.3390/ijms19071916
Chicago/Turabian StyleAliwarga, Theresa, Eric A. Evangelista, Nona Sotoodehnia, Rozenn N. Lemaitre, and Rheem A. Totah. 2018. "Regulation of CYP2J2 and EET Levels in Cardiac Disease and Diabetes" International Journal of Molecular Sciences 19, no. 7: 1916. https://doi.org/10.3390/ijms19071916
Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.
